Bøtker, Hans Erik http://orcid.org/0000-0001-6358-8962
Hausenloy, Derek
Andreadou, Ioanna
Antonucci, Salvatore
Boengler, Kerstin
Davidson, Sean M.
Deshwal, Soni
Devaux, Yvan
Di Lisa, Fabio
Di Sante, Moises
Efentakis, Panagiotis
Femminò, Saveria
García-Dorado, David
Giricz, Zoltán
Ibanez, Borja
Iliodromitis, Efstathios
Kaludercic, Nina
Kleinbongard, Petra
Neuhäuser, Markus
Ovize, Michel
Pagliaro, Pasquale
Rahbek-Schmidt, Michael
Ruiz-Meana, Marisol
Schlüter, Klaus-Dieter
Schulz, Rainer
Skyschally, Andreas
Wilder, Catherine
Yellon, Derek M.
Ferdinandy, Peter
Heusch, Gerd http://orcid.org/0000-0001-7078-4160
Funding for this research was provided by:
The Danish Council for Strategic Research (11-108354, 11-108354)
Novo Nordisk Fonden (ConBis, ConBis)
TrygFonden (.., ..)
British Heart Foundation (FS/10/039/28270)
National Institute for Health Research University College London Hospitals (..)
Duke National University Singapore Medical School (..)
Singapore Ministry of Health’s National Medical Research Council and its Clinician Scientist-Senior Investigator scheme (NMRC/CSA-SI/0011/2017)
Health’s National Medical Research Council and Collaborative Centre Grant scheme (NMRC/GGAug16C006)
Hungarian National Research, Development, and Innovation Office (OTKA K 109737, OTKA KH_17 125570, NVKP 16-1-2016-0017, VEKOP-2.3.2-16-2016-00002)
Ministry of Human Capacities (..)
Bolyai Scholarship by the Hungarian Academy of Sciences (..)
Deutsche Forschungsgemeinschaft (He 1320718-3, SFB 1116 B8, SFB 1116 B8)
Article History
Received: 30 May 2018
Revised: 18 July 2018
Accepted: 3 August 2018
First Online: 17 August 2018
Compliance with ethical standards
:
: HEB and MRS are shareholders in CellAegis Inc. PF is founder and CEO of Pharmahungary, a Group of R&D companies.